The World Health Organization has issued an advisory regarding the presence of a contaminated batch of METHOTREX 50 mg in the WHO Eastern Mediterranean Region.
This was stated by the organization in a statement It was posted on his official website on Tuesdaythat the contaminated batch was found in Yemen and Lebanon, after adverse effects appeared on sick children receiving the drug, indicating that the two countries’ health authorities conducted microbiological tests on the remaining sealed vials, and the test results revealed the presence of Pseudomonas aeruginosa bacteria, which is what indicates product contamination.
The organization stressed “the need to detect contaminated products and withdraw them from circulation to prevent harm to patients” and called for greater surveillance and caution at the level of supply chains in countries and territories potentially affected by this product.
The organization also advised to increase monitoring at the level of informal markets, and urged the relevant authorities to notify them immediately if this product has been discovered in the markets of their countries.
The World Health Organization has urged manufacturing companies to conduct tests for microbial contamination before releasing batches of finished products for use and stressed the need to obtain medicines through approved and licensed suppliers and to carefully check authenticity and the physical condition of the products.
The drug drops It is included in the WHO Model List of Essential MedicinesIt is an immunosuppressive chemotherapy agent prescribed for the treatment of cancer and autoimmune diseases. Pseudomonas aeruginosa infection in the bloodstream is a serious infection that can lead to death, and any contaminated product injected directly into the body can pose serious risks to patients.
